ARK Genomic Revolution ETFARK Genomic Revolution ETFARK Genomic Revolution ETF

ARK Genomic Revolution ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪1.28 B‬USD
Fund flows (1Y)
‪−305.81 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
1.9%

About ARK Genomic Revolution ETF


Issuer
ARK Investment Management LP
Brand
ARK
Expense ratio
0.75%
Home page
Inception date
Oct 31, 2014
Index tracked
No Underlying Index
Management style
Active
ARKG reaches across multiple sectors and geographies for companies that the advisor believes will benefit from innovations in the genomics-related industry. Such companies are those that may develop, produce or enable targeted therapeutics, bioinformatics, stem cells or molecular diagnostics. The reality is almost all of its holdings are in US healthcare-related companies, with biotech naturally leading the way. This is a niche fund which employs an actively-managed strategy, hence investors should look closely at where the fund makes its bets before investing.

Classification


Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Active
Weighting scheme
Proprietary
Selection criteria
Proprietary
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Technology Services
Stock breakdown by region
100%

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.